<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3272">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02040701</url>
  </required_header>
  <id_info>
    <org_study_id>TASMC-13-RT-06-122-CTIL</org_study_id>
    <nct_id>NCT02040701</nct_id>
  </id_info>
  <brief_title>Sleep Disordered Breathing in Children: Inflammation and Oxidative Stress</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel-Aviv Sourasky Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tel-Aviv Sourasky Medical Center</source>
  <oversight_info>
    <authority>Israel: Ministry of Health</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to measure markers of inflammatory and oxidative stress known to
      be associated with cardiovascular morbidity in snoring children.

      In addition, to measure markers of local inflammation and to evaluate the response to
      treatment.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2006</start_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <target_duration>8 Weeks</target_duration>
  <primary_outcome>
    <measure>Plasma inflammatory-markers</measure>
    <time_frame>After  the blood analyzed</time_frame>
    <safety_issue>No</safety_issue>
    <description>Sleep disordered breathing (SDB)  in children is associated with increased markers of inflammation, atherogenesis and oxidative stress.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Sleep Disordered Breathing (SDB)</condition>
  <condition>Endothelial Dysfunction</condition>
  <arm_group>
    <arm_group_label>SDB group</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        children ages 6 months-18 years who will undergo overnight sleep study at the Dana
        Children's hospital, Tel Aviv Medical Center because of snoring and suspected
        sleep-disordered breathing or will attend the pre-operative ENT clinic for adenoidectomy
        or adenotonsillectomy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  children ages 6 months-18 years

          -  suspected sleep-disordered breathing or will attend the pre-operative ENT clinic for
             adenoidectomy or adenotonsillectomy

        Exclusion Criteria:

          -  craniofacial abnormalities

          -  neurological disorders

          -  genetic disorders

          -  infectious disease

          -  chronic inflammatory disease

          -  any underlying chronic medical condition
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Riva Tauman, Dr.</last_name>
    <email>tauman@tlvmc.gov.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Dana Children's hospital, Tel Aviv Medical Center</name>
      <address>
        <city>Tel-Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Riva Tauman, Dr.</last_name>
      <email>tauman@tlvmc.gov.il</email>
    </contact>
    <investigator>
      <last_name>Riva Tauman, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 15, 2014</lastchanged_date>
  <firstreceived_date>January 9, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Respiratory Aspiration</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
